SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1MEF - Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]:
SEC Accession No. 0001213900-20-038140
Filing Date
2020-11-19
Accepted
2020-11-19 09:33:30
Documents
8
Effectiveness Date
2020-11-19

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea130190-f1mef_therapixbio.htm F-1MEF 75880
2 OPINION OF MEITAR | LAW OFFICES, ISRAELI LEGAL COUNSEL TO THE REGISTRANT ea130190ex5-1_therapixbio.htm EX-5.1 11293
3 OPINION OF SULLIVAN & WORCESTER LLP, U.S. COUNSEL TO THE REGISTRANT. ea130190ex5-2_therapixbio.htm EX-5.2 11221
4 CONSENT OF KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL ea130190ex23-1_therapixbio.htm EX-23.1 2562
5 GRAPHIC image_001.jpg GRAPHIC 21121
6 GRAPHIC image_002.jpg GRAPHIC 13126
7 GRAPHIC ex5-1_001.jpg GRAPHIC 27463
8 GRAPHIC ex5-1_002.jpg GRAPHIC 5009
  Complete submission text file 0001213900-20-038140.txt   194409
Mailing Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608
Business Address 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1MEF | Act: 33 | File No.: 333-250193 | Film No.: 201327297
SIC: 2834 Pharmaceutical Preparations